A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study

BACKGROUND: We sought to estimate the maximum tolerated or recommended phase 2 dose and describe the pharmacokinetics and toxicities of enzastaurin, an oral inhibitor of protein kinase Cβ, in children with recurrent central nervous system malignancies. METHODS: Enzastaurin was administered continuou...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Kilburn, Lindsay B., Kocak, Mehmet, Decker, Rodney L., Wetmore, Cynthia, Chintagumpala, Murali, Su, Jack, Goldman, Stewart, Banerjee, Anuradha, Gilbertson, Richard, Fouladi, Maryam, Kun, Larry, Boyett, James M., Blaney, Susan M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2015
Onderwerpen:
Pediatric Neuro-Oncology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4288513/
https://ncbi.nlm.nih.gov/pubmed/25431212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou114
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items